FDA Investigator Ramcharan S Khalsa
Ramcharan S Khalsa has conducted inspections on 24 sites in 1 countries as of 04 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
04 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ramcharan S Khalsa:
Aldo J Quintana,
Alfred P Pistorio,
Alice C Silva,
Alysia M Salonia,
Anne E Carpenter,
Anthony P Costello,
Arie C Menachem,
Ashley M Whitehurst,
Atricia L Irons,
Bradford L Swanson,
Brenda P King,
Carla E Lavallee,
Christine L Williams,
Christopher K Vantwuyver,
Christopher M Elliott,
Clinton V Giustra,
Darin S Wiegers,
Dean R Rugnetta,
Douglas S Joslin,
Elise L Mcdevitt,
Emily J Schramm,
Erich P Garger,
Frank J Koch,
Gerard D Difiore,
Intkhab H Wahla,
Jamie S Mathews,
Jay M Patria,
Jeffery A Hangartner,
Jessica D Spellman,
John A Sciacchitano,
John L Zaccone,
John P Shelton,
John R Carlson,
Joseph B Cascio,
Joseph Foley,
Joseph H Procopio, Jr,
Joseph T Frost,
Joshua L Gibbs,
Joyce A Kellett,
Justine M Corson,
Kathleen E Mcafoose,
Kent A Conforti,
Lauren M Lawrance,
LCDR Debra Emerson,
Leo B Zadecky,
Liz M Otero,
Lorayne A Mcguinness,
Louis Christy,
Marcia M Laughrey,
Margaret E Walsh,
Mark E Farrell,
Martin J Guardia,
Mary Jeanet Mcgarry,
Michael J Pasternak,
Michelle M Noe Varga,
Nasser Yazdani, DVM, MPH,
Nichole B Murphy,
Osama A Khatib,
Pamela L Ogonowski,
Richard F Hapke,
Richard L Licari,
Rupa Pradhan,
Sean M Tessicini,
Slater K Bartlett,
Stephen C King,
Stephen C Smith,
Steven M Ferrara,
Teddy Tom,
Thomas Cote,
Thomas J Kelly,
Thomas Siebertz,
Thomas W Nerney,
Troy R Petrillo,
Victoria Taylor,
Wendy A Johnecheck
Ramcharan S Khalsa's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2017 | FDA 483 | Taylor Farm, Inc. - Form 483, 2017-05-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more